Published in Vaccine Weekly, December 14th, 1998
Tulsa is one of a handful of cities chosen to participate in final testing of the AIDSvax vaccine, developed by California-based VaxGen Inc.
Researchers are recruiting HIV negative gay men who are considered at high risk of contracting the disease. That includes those who are not in monogamous relationships. They also seek women who are in sexual relationships with HIV positive men or who have had more than one male sexual partner and have been diagnosed with sexually transmitted diseases within the past year.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.